News

CCC 2014: Mobile Devices and Information Technology for Improving Care

While modern medicine is heavily dependent on sophisticated technologies to diagnose and treat disease, health care generally lags behind other sectors in adopting advances in information technology. A number of presentations at the 2014 Canadian Cardiovascular Congress looked at ways in which

New Heart Failure Drug Promises to Improve Outcomes for Patients

More than half a million Canadians are living with heart failure and another 50,000 join their ranks each year. The standard treatment for heart failure has not changed for quite some time. Now, a new drug—so new that it’s identified only as LCZ696—is generating interest among cardiologists and

CCC 2014: Recent Advances in the Management of Atrial Fibrillation

Until the new oral anticoagulant (NOAC) drugs became available, beginning in 2009, warfarin was the workhorse for managing stroke risk in patients with atrial fibrillation. In his Research Achievement Award presentation, Stuart Connolly, MD, of McMaster University in Hamilton, Ont., provided a

CCC and AHA 2014: Overcoming Challenges to Repair Heart Attack Damage

We know the best ways to prevent a heart attack. Healthy eating, being physically active and not smoking are key among them. And advances in cardiac care are helping people live longer and with a better quality of life if they do have a heart attack. But there is no way to repair the damage and

CCC 2014: Seeing Inside the Heart

At the 2014 Canadian Cardiovascular Congress and American Heart Association Scientific Sessions, Heart Institute researchers presented several studies that tested novel ways to visualize the heart’s structure and function. Developing methods to predict which plaques in the arteries may be at high

AHA 2014 Highlights

Research from around the world was presented at the 2014 American Heart Association (AHA) Scientific Sessions in November. The following highlights range from large drug trials to new information about the causes and of heart disease and the value of good heart health. Preventing Clots Following

CCC and AHA 2014 Conference Highlights

Read detailed coverage of CCC and AHA 2014 – highlights include text messaging and mobile apps for health promotion, updates on atrial fibrillation and the future of cardiac rehabilitation. CCC 2014: Presentations and Activities Schedule (pdf) AHA 2014: Presentations and Activities Schedule (pdf)

CCC 2014: Gaining Weight Over Time Can Start the Process of Heart Disease

The arteries in our body are lined with a layer of cells called the endothelium. The very first step in the development of cardiovascular disease—the primary cause of heart attack and stroke—takes place when the endothelium begins to function abnormally. In research presented at the Canadian

CCC 2014:Heart Institute Program Guide

The Canadian Cardiovascular Congress travels to the West Coast this year. With topics ranging from sedentary behaviour to stem cells, the University of Ottawa Heart Institute has more than 90 items on the program at CCC 2014. Our program guide will help you find them all. Presentations and

Global Ranking Confirms the High Impact of Heart Institute Research

The latest global ranking of research organizations from Scimago Institutions Rankings (SIR) recognizes the continued excellence and vitality of research at the University of Ottawa Heart Institute, placing it 159th out of 4,851 institutions worldwide, across all fields of study. In Canada, the